Chromogranin A expression correlates with tumour cell type and prognosis in signet ring cell carcinoma of the stomach

Histopathology

Volumn 52, Issue 3, 2008, Pages 305-313

  Fujiyoshi, Y ^a   Eimoto, T ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Chromogranin A; Neuroendocrine differentiation; Prognosis; Signet ring cell carcinoma; Stomach

Indexed keywords

CHROMOGRANIN A;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER SURVIVAL; CELL TYPE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; SIGNET RING CARCINOMA; STOMACH CARCINOMA; TUMOR CELL; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SIGNET RING CELL; CHROMOGRANIN A; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 38849107988     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2007.02950.x     Document Type: Article

References (39)

1. Fenoglio-Preiser CM, Noffsinger AE, Belli J et al. Pathological and phenotypic features of gastric cancer. Semin. Oncol. 1996 123 292 306.
2. Maehara Y, Sakaguchi Y, Moriguchi S et al. Signet ring cell carcinoma of the stomach. Cancer 1992 69 1645 1650.
3. Otsuji E, Yamaguchi T, Sawai K et al. Characterization of signet ring cell carcinoma of the stomach. J. Surg. Oncol. 1998 67 216 220.
4. Antonioli DA, Goldman H. Changes in the location and type of gastric adenocarcinoma. Cancer 1982 50 775 781.
5. Henson DE, Dittus C, Younes M et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000 - increase in the signet ring cell type. Arch. Pathol. Lab. Med. 2004 128 765 770.
6. Fenoglio-Preiser C, Carneiro F, Correa P et al. Gastric carcinoma. In Hamilton SR, Aaltonen LA eds. Pathology and genetics: tumors of the digestive system (WHO classification of tumor pathology). Lyon : IAP IRAC Press, 2000 39 52.
7. Azzopardi JG, Pollock DJ. Argentaffin and argylophil cells in gastric carcinoma. J. Pathol. Bacteriol. 1963 86 443 451.
8. Blumenfeld W, Chandhoke DK, Sagerman P et al. Neuroendocrine differentiation in gastric adenocarcinoma - an immunohistochemical study. Arch. Pathol. Lab. Med. 1996 120 478 481.
9. Waldum HL, Aase S, Kvetnoi I et al. Neuroendocrine differentiation in human gastric carcinoma. Cancer 1998 83 435 444.
10. Fujii A, Kamiakito T, Takayashiki N et al. Neuroendocrine tissue-specific transcription factor, BETA2/NeuroD, in gastric carcinomas - a comparison with chromogranin A and synaptophysin expressions. Pathol. Res. Pract. 2003 199 513 519.
11. Eren F, Çelikei Ç, Güllüoglu B. Neuroendocrine differentiation in gastric adenocarcinomas - correlation with tumor stage and expression of VEGF and p53. Pathol. Oncol. Res. 2004 10 47 51.
12. Waldum HL, Haugen OA, Isaksen C et al. Are diffuse carcinomas neuroendocrine tumors (ECL-omas)? Eur. J. Gastroenterol. Hepatol. 1991 3 245 249.
13. Ooi A, Mai M, Ogino T et al. Endocrine differentiation of gastric adenocarcinoma - the prevalence as evaluated by immunoreactive chromogranin A and its biologic significance. Cancer 1988 62 1096 1104.
14. Qvigstat G, Sandvic A, Brenna E et al. Detection of chromogranin A in human gastric adenocarcinoma using a sensitive immunohistochemical technique. Histochem. J. 2000 32 551 556.
15. Lewin KJ, Appelman HD. Mixed endocrine and non-endocrine epithelial tumors. In Rosai J, Sobin LH eds. Tumors of the esophagus and stomach. Atlas of tumor pathology, Fascicle 18. Washinton : AFIP, 1996 351 352.
16. Fujiyoshi Y, Kuhara H, Eimoto T. Composite glandular-endocrine cell carcinoma of the stomach - report of two cases with goblet cell carcinoid component. Pathol. Res. Pract. 2005 200 823 829.
17. Radi MJ, Fenoglio-Preiser CM, Bartow SA et al. Gastric carcinoma in the young - a clinicopathological and immunohistochemical study. Am. J. Gastroenterol. 1986 81 747 756.
18. Morii S, Oka K, Hakozaki H. CEA-producing mucin-negative gastric signet-ring cell carcinoma with neuroendocrine markers - a case report. J. Clin. Gastroenterol. 1999 29 82 85.
19. Sugihara A, Nakasho K, Yamada N. Neuroendocrine differentiation of periodic-acid Schiff and alcian blue-negative signet-ring cell-like cells and tubular adenocarcinoma cells within a gastric cancer. Scand. J. Gastroenterol. 2004 8 795 800.
20. Tahara E, Haizuka S, Kodama T et al. The relationship of gastrointestinal endocrine cells to gastric epithelial changes with special references to gastric cancer. Acta Pathol. Jpn 1975 25 161 177.
21. Prade M, Bara J, Gadenne C et al. Gastric carcinoma with argyrophilic cells - light microscopic, electron microscopic, and immunochemical study. Hum. Pathol. 1982 13 588 592.
22. Rindi G, Buffa R, Sessa F et al. Chromogranin A, B and C immunoreactivities of mammalian endocrine cells - distribution, distinction from costored hormones/prohormones and relationship with the argylophil component of secretory granules. Histochemistry 1986 85 19 28.
23. Wick MR. Immunohistology of neuroendocrine and neuroectodermal tumors. Semin. Diagn. Pathol. 2000 17 194 203.
24. Japanese Gastric Cancer Association. Japanese Classification of gastric carcinomas, 2nd English edn. Gastric Cancer 1998 1 10 24.
25. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques. J. Histochem. Cytochem. 1981 29 577 580.
26. Siewert JR, Böttner K, Stein HJ et al. Relevant prognostic factors in gastric cancer - ten-year results of the German gastric cancer study. Ann. Surg. 1998 228 449 461.
27. Adachi Y, Yasuda K, Inomata M et al. Pathology and prognosis of gastric carcinoma - well versus poorly differentiated type. Cancer 2000 89 1418 1424.
28. Kim JP, Kim SC, Yang HK. Prognostic significance of signet ring cell carcinoma of the stomach. Surg. Oncol. 1994 3 221 227.
29. Kim DY, Park YK, Joo JK et al. Clinicopathological characteristics of signet ring cell carcinoma of the stomach. ANZ J. Surg. 2004 74 1060 1064.
30. Kunisaki C, Shimada H, Nomura G et al. Therapeutic strategy for signet ring cell carcinoma of the stomach. Br. J. Surg. 2004 91 1319 1324.
31. Hyung WJ, Noh SH, Lee JH et al. Early gastric carcinoma with signet ring cell histology. Cancer 2002 94 78 83.
32. Theuer CP, Nastanski F, Brewstar WR et al. Signet ring cell histology is associated with unique clinical features but does not affect gastric cancer survival. Am. Surg. 1999 65 915 921.
33. Yamashiro K, Suzuki H, Nagayo T. Electron microscopic study of signet-ring cells in diffuse carcinoma of the human stomach. Virchows Arch. A 1977 374 275 284.
34. Sugihara H, Hattori T, Fukuda M et al. Cell proliferation and differentiation in intramucosal and advanced signet ring cell carcinoma of the human stomach. Virchows Arch. A 1987 411 117 127.
35. Akamatsu T, Katsuyama T. Histochemical demonstration of mucins in the intramucosal laminated structure of human gastric signet ring cell carcinoma and its relation to submucosal invasion. Histochem. J. 1990 22 416 425.
36. r 38,000 characteristic of presynaptic vesicles. Cell 1985 41 1017 1028.
37. Loy TS, Darcow GVD, Quesenberry JT. Immunostaining in the diagnosis of pulmonary neuroendocrine carcinomas - an immunohistochemical study with ultrastructural correlations. Am. J. Surg. Pathol. 1995 19 173 182.
38. Wilson BS, Lloyd RV. Detection of chromogranin in neuroendocrine cells with a monoclonal antibody. Am. J. Pathol. 1984 115 458 468.
39. Bakkelund K, Fossmark R, Nordrum I et al. Signet ring cells in gastric carcinomas are derived from neuroendocrine cells. J. Histochem. Cytochem. 2006 54 615 621.